Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.
• Zhejiang Starry Pharmaceutical announced a annually dividend of ¥0.05 per ordinary share which will be made payable on 2024-09-09. Ex dividend date: 2024-09-09 • Zhejiang Starry Pharmaceutical annual dividend for 2024 was ¥0.05 • Zhejiang Starry Pharmaceutical annual dividend for 2023 was ¥0.20 • Zhejiang Starry Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.55% • Zhejiang Starry Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 868.95% • Zhejiang Starry Pharmaceutical's dividend growth over the last five years (2018-2023) was -16.74% year
Zhejiang Starry Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.55%. Interested in purchasing Zhejiang Starry Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Zhejiang Starry Pharmaceutical Financial Ratios
P/E ratio287.53
PEG ratio2.89
P/B ratio1.50
ROE0.63%
Payout ratio868.95%
Current ratio0.90
Quick ratio0.49
Cash Ratio0.27
Zhejiang Starry Pharmaceutical Dividend FAQ
How much is the next Zhejiang Starry Pharmaceutical dividend?
Zhejiang Starry Pharmaceutical's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Zhejiang Starry Pharmaceutical dividend. The next Zhejiang Starry Pharmaceutical dividend will be released in June.
When is Zhejiang Starry Pharmaceutical dividend paid?
Zhejiang Starry Pharmaceutical pays dividends on a annually basis. The specific dates may vary each year but are generally around June. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Zhejiang Starry Pharmaceutical pay?
The specific amount of Zhejiang Starry Pharmaceutical dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Zhejiang Starry Pharmaceutical's dividend history.
Does Zhejiang Starry Pharmaceutical stock pay dividends?
Yes, Zhejiang Starry Pharmaceutical does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Zhejiang Starry Pharmaceutical's dividend history.
How much dividend does Zhejiang Starry Pharmaceutical pay?
Zhejiang Starry Pharmaceutical paid ¥0.05 in 2024, ¥0.2 in 2023, ¥0.7 in 2022, ¥0.5 in 2021, and ¥0.35 in 2020.
How often does Zhejiang Starry Pharmaceutical pay dividends?
Zhejiang Starry Pharmaceutical typically pays dividends on a annually basis. This means that dividends are usually distributed 1 times a year. The specific payout dates may vary each year but generally fall around June.
What is Zhejiang Starry Pharmaceutical's dividend yield?
The current dividend yield for Zhejiang Starry Pharmaceutical is 0.55%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Zhejiang Starry Pharmaceutical's exact dividend yield.
When does Zhejiang Starry Pharmaceutical go ex dividend?
Zhejiang Starry Pharmaceutical's ex-dividend date for the latest dividend was on 2024-09-09. Zhejiang Starry Pharmaceutical typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Zhejiang Starry Pharmaceutical dividend paid?
Zhejiang Starry Pharmaceutical pays dividends on a annually basis, typically around June, but the exact dates can vary each year.
Will Zhejiang Starry Pharmaceutical increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Zhejiang Starry Pharmaceutical will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Zhejiang Starry Pharmaceutical dividend per share?
Zhejiang Starry Pharmaceutical paid ¥0.05 per share in 2024 and ¥0.2 per share in 2023. The amount of dividend per share that Zhejiang Starry Pharmaceutical pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Zhejiang Starry Pharmaceutical a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Zhejiang Starry Pharmaceutical a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Zhejiang Starry Pharmaceutical a dividend stock?
Yes, Zhejiang Starry Pharmaceutical is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Zhejiang Starry Pharmaceutical a good dividend stock?
Whether Zhejiang Starry Pharmaceutical is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Zhejiang Starry Pharmaceutical has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating Zhejiang Starry Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Zhejiang Starry Pharmaceutical pay dividends monthly?
Zhejiang Starry Pharmaceutical typically pays dividends on a annually basis.
Does Zhejiang Starry Pharmaceutical pay dividends quarterly?
Zhejiang Starry Pharmaceutical currently pays dividends on a annually basis.
Has Zhejiang Starry Pharmaceutical ever paid a dividend?
Yes, Zhejiang Starry Pharmaceutical has a history of paying dividends to its shareholders. Zhejiang Starry Pharmaceutical is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Zhejiang Starry Pharmaceutical dividend stocks?
To buy Zhejiang Starry Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy Zhejiang Starry Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Zhejiang Starry Pharmaceutical pay dividends 2024?
Zhejiang Starry Pharmaceutical pays dividends on a annually basis. 2024 dividend payments are in 2024-09-09. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Zhejiang Starry Pharmaceutical increase its dividend in 2024?
Decisions regarding Zhejiang Starry Pharmaceutical dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Zhejiang Starry Pharmaceutical dividend overview you can look into the above table of dividend history.
How Zhejiang Starry Pharmaceutical dividend works?
The Zhejiang Starry Pharmaceutical dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Zhejiang Starry Pharmaceutical's dividend process works:
1. Determination of Dividend: Zhejiang Starry Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Zhejiang Starry Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Zhejiang Starry Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Zhejiang Starry Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Zhejiang Starry Pharmaceutical dividends paid?
Zhejiang Starry Pharmaceutical dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: Zhejiang Starry Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Zhejiang Starry Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Zhejiang Starry Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Zhejiang Starry Pharmaceutical pay dividends?
Zhejiang Starry Pharmaceutical typically pays dividends on a annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Zhejiang Starry Pharmaceutical pay dividends?
The general pattern is that Zhejiang Starry Pharmaceutical pays dividends around June. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Zhejiang Starry Pharmaceutical dividend safe?
The safety of Zhejiang Starry Pharmaceutical's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of Zhejiang Starry Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Zhejiang Starry Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.